News & Events
View recent news stories and events relating to Research and the Providence Health Care Research Institute.
Researchers and research staff from across the organization are invited to a meet-and-greet event with the Providence Health Care Research Institute (PHCRI). Our new President Dr. Darryl Knight will introduce himself and his vision for the future. Following his presentation, enjoy some refreshments while you mix and mingle. Dr. Knight and our PHCRI Department Managers will be available to answer your questions.
In 2017, Providence Health Care senior administrator Scott Harrison ended up in the hospital with septic shock. Read his personal story and learn what researchers at the Centre for Heart Lung Innovation are doing to improve the prevention, diagnosis and treatment of sepsis and septic shock.
September is Sepsis Awareness Month and Dr. Jim Russell, a Principal Investigator at the Centre for Heart Lung Innovation (HLI) at St. Paul’s Hospital, is being recognized as the world’s top expert in septic shock.
Researchers at St. Paul’s are involved in an international study to determine whether the Polycap (a single pill containing multiple medications) reduces the risk of cardiovascular disease events.
People living with osteoarthritis are at an increased risk of cardiovascular disease compared to the general population. the reason is not known but some preliminary research suggests that non-steroidal anti-inflammatory drugs (NSAIDS) could play a role.
Dr. Knight is the new Vice-President, Research & Academic Affairs, Providence Health Care, and President of the Providence Health Care Research Institute.
B.C. saw a significant 40 per-cent jump in infectious syphilis cases from 2015 to 2016 and 30- to 35-per cent from 2017 to 2018.
Learn how PHC researchers are helping respond to the overdose crisis through research, teaching and community engagement.
Researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) at St. Paul’s Hospital are monitoring and evaluating the hepatitis C epidemic in BC. Research scientist Dr. Kate Salters shares the basics on hep C and explains what’s being done to eliminate the disease.
Drs. Liam Brunham, Simon Pimstone and Karin Humphries were all involved in this retrospective study.
Dr. Zachary Laksman, a specialist in heart-rhythm disorders at Providence Health Care and Principal Investigator with the Centre for Heart Lung Innovation, has been named a Recipient of Canada’s Top 40 Under 40 for 2019.
The funding will support the renewal of the CIHR Canadian HIV Trials Network (CTN), whose National Centre is based at St. Paul’s.
Providence Health research group receives federal funds to support survivors of gender-based violence
The federal government is providing $1 million to the Centre for Gender and Sexual Health Equity for a project to to support survivors of gender-based violence in Vancouver.
Dr. Don Sin, staff respirologist at St. Paul’s Hospital and the Head of Respiratory Medicine at Providence Health Care, discusses the effects of smoke on our health.
The Providence Health Care research community converged on the Century Plaza Hotel June 7 for a morning of celebration, education and networking.
Dr. James and Robert Hogg both have deep connections to Providence Health Care, are both renowned researchers in their respective fields and are both recipients of the Order of Canada.
A recent European study that concluded women have lower chances than men of surviving a cardiac arrest outside of a hospital is consistent with the work of two Providence Health Care researchers.
Findings from a sweeping global study conducted by Dr. Scott Lear, among others, reveal a direct correlation between socioeconomic status and one’s susceptibility to heart attacks and strokes.
Federal Health Minister Ginette Pettipas Taylor made the announcement as part of the international conference on gender equity, Women Deliver being held in Vancouver.
For many people with chronic obstructive pulmonary disease or COPD, a steroid inhaler is a daily necessity to keep their airways open and help them to breathe. Now, a new UBC analysis shows that these medicated devices may also reduce patients’ risk of lung cancer by as much as 30 per cent.